Rapid, evidence-based reviews of genetic tests

Human Genome Epidemiology: Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease: Second Edition

Volumn , Issue , 2010, Pages

  Gudgeon, James M ^a   Palomaki, Glenn E ^b   Williams, Marc S ^a  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Evidence based review; Genetic tests; Genomic information

Indexed keywords

EID: 84921258302     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195398441.003.0024     Document Type: Chapter

References (30)

1. U.S. Preventive Services Task Force. Available at. Accessed December 29, 2008.
2. Center for Medicare & Medicaid Services (CMS). Available at. Accessed December 29, 2008.
3. Leeflang MMG, Deeks JJ, Gatsonis C, Bossuyt PMM; on behalf of the Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med December 2008; 149 (12):889-897.
4. UK Department of Health Genetic Testing Network (UKGTN). Available at. Accessed December 29, 2008.
5. National Institutes of Health-Department of Energy (NIH-DOE) Task Force on Promoting Safe and Effective Genetic Testing in the United States. Available at. Accessed December 29, 2008.
6. Department of Health and Human Services (DHHS), Secretary's Advisory Committee on Genetic Testing, Enhancing the Oversight of Genetic Tests. Available at. Accessed December 29, 2008.
7. Haddow J, Palomaki G. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury M, Little J, Burke W, editors. Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease New York: Oxford University Press; 2003:217-233.
8. Sanderson S, Zimmern R, Kroese M, et al. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genet Med September 2005; 7 (7):495-500.
9. Márquez-Calderón S, Pérezde la Blanca EB. Framework for the Assessment of Genetic Testing in the Andalusian Public Health System Sevilla: Agencia de Evaluación de Tecnologías Sanitarias de Andalucía; 2006.
10. Teutsch SM, Bradley LA, Palomaki GE, et al. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med January 2009; 11 (1):3-14.
11. Gudgeon JM, McClain MR, Palomaki GE, Williams MS. Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing. Genet Med July 2007; 9 (7):473-478.
12. Burke W, Ron Zimmern. Moving Beyond ACCE: An Expanded Framework for Genetic Test Evaluation. A paper for the United Kingdom Genetic Testing Network, September 2007. Available at. Accessed December 29, 2008.
13. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. EGAPP Recommendation Statement. Genet Med December 2007; 9 (12):819-825. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Available at. Accessed December 29, 2008.
14. McClain MR, Palomaki GE, Haddow JE. An Abbreviated ACCE Review of BMPR2 Mutation Testing Among Individuals Diagnosed with Familial or Idiopathic Pulmonary Arterial Hypertension. Institute for Preventive Medicine, Gray, Maine. Available at. Accessed December 29, 2008.
15. McClain MR, Palomaki GE, Piper M, Haddow JE. Commissioned by American College of Medical Genetics (ACMG). A rapid ACCE review of CYP2C9 and VKORC1 allele testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding. Updated August 20, 2007. See Chapter 31, A rapid ACCE review of CYP2C9 and VKORC1 allele testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding in this volume.
16. EGAPP stakeholder's group. Available at. Accessed December 29, 2008.
17. Williams MS. Insurance coverage for pharmacogenomic testing. Per Med 2007; 4:479-487.
18. Teutsch S. Issues in Adjusting the Evidence to Decision Needs. Presentation during the Institute of Medicine Workshop: Judging the Evidence: Standards for Determining Clinical Effectiveness, February 5, 2007. Available at. Accessed December 29, 2008.
19. Burke W, Zimmern RL, Kroese M. Defining purpose: a key step in genetic test evaluation. Genet Med October 2007; 9 (10):675-681.
20. Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol August 2006; 187 (2):271-281.
21. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol July 12, 2006; 6:31.
22. Ramsey SD, Veenstra DL, Garrison LP, Jr, et al. Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests. Am J Manag Care April 2006; 12 (4):197-202.
23. Payne K, Nicholls SG, McAllister M, et al. Outcome measures for clinical genetics services: a comparison of genetics healthcare professionals and patients' views. Health Policy November 2007; 84 (1):112-122.
24. Loscalzo J, Kohane I, Barabasi AL. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol 2007; 3:124.
25. From Wikipedia, the free encyclopedia: "Systems biology." Available at. Accessed December 29, 2008.
26. Subramonia-Iyer S, Sanderson S, Sagoo G, et al. Array-based comparative genomic hybridization for investigating chromosomal abnormalities in patients with learning disability: systematic review meta-analysis of diagnostic and false-positive yields. Genet Med February 2007; 9 (2):74-79.
27. Eddy DM. Investigational treatments. How strict should we be? JAMA July 16, 1997; 278 (3):179-185.
28. Aronson N. Assessing technology for use in health and medicine. In: Hernandez LM (Reporter), Institute of Medicine of the National Academies. Diffusion and Use of Genomic Innovations in Health and Medicine Washington DC: The National Academies Press; 2008:29-33.
29. The Collaboration, Education and Test Translation (CETT) Program. Available at. Accessed December 18, 2007.
30. Grosse SD, Wordsworth S, Payne K. Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis. Genet Med September 2008; 10 (9):648-654.